Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Aug 6, 2021; 9(22): 6268-6277
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6268
Table 1 Demographics of the groups

WVT
NWVT
P value
Number6565-
Male/female32/3333/320.862
Age (yr)60.42 ± 6.3959.82 ± 6.620.600
Height (cm)165.71 ± 7.73165.83 ± 7.160.925
Weight (kg)67.33 ± 7.7066.03 ± 7.830.339
Course of disease3.22 ± 1.353.09 ± 1.010.557
Hematencephalon41370.478
Cerebral infarction2428
Affected side (L/R)36/2932/330.486
Table 2 Assessment of balance and functional mobility parameters
WVT
NWVT
WVT vs NWVT
mean ± SD
P value
mean ± SD
P value
P value
Berg balance scale
Baseline27.75 ± 2.870.000126.92 ± 3.240.00010.124
After treatment46.08 ± 3.4140.22 ± 3.750.000
Amount of change18.32 ± 2.1813.29 ± 1.660.000
Time up-and-go (s)
Baseline50.13 ± 3.910.000150.32 ± 3.380.00010.768
After treatment32.64 ± 3.8139.56 ± 3.680.000
Amount of change17.49 ± 1.8810.76 ± 1.420.000
Maximum walking speed (s)
Baseline19.52 ± 2.030.000119.89 ± 2.100.00010.307
After treatment12.73 ± 2.2615.04 ± 2.270.000
Amount of change6.79 ± 0.814.84 ± 0.580.000
Functional reaching (cm)
Baseline10.47 ± 1.950.000110.44 ± 2.610.00010.930
After treatment20.48 ± 2.2316.60 ± 2.820.000
Amount of change10.00 ± 0.926.16 ± 0.950.000